Viewing Study NCT05821933


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-31 @ 2:15 AM
Study NCT ID: NCT05821933
Status: RECRUITING
Last Update Posted: 2024-04-10
First Post: 2023-03-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module